See more : Vector Inc. (6058.T) Income Statement Analysis – Financial Results
Complete financial analysis of XWELL, Inc. (XWEL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of XWELL, Inc., a leading company in the Personal Products & Services industry within the Consumer Cyclical sector.
You may be interested
- RMG Acquisition Corp. III (RMGCU) Income Statement Analysis – Financial Results
- GREEN MONSTER INC (157A.T) Income Statement Analysis – Financial Results
- Innovative Pharmaceutical Biotech Limited (0399.HK) Income Statement Analysis – Financial Results
- Drive Shack Inc. (DSHK) Income Statement Analysis – Financial Results
- Kamdhenu Ventures Limited (KAMOPAINTS.BO) Income Statement Analysis – Financial Results
XWELL, Inc. (XWEL)
About XWELL, Inc.
XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.11M | 55.94M | 73.73M | 8.39M | 48.52M | 50.09M | 48.82M | 18.97M | 22.69M | 1.43M | 1.10M | 369.00K | 718.00K | 211.00K | 20.00K | 0.00 |
| Cost of Revenue | 26.43M | 43.89M | 41.30M | 11.98M | 37.85M | 39.45M | 39.34M | 12.82M | 19.35M | 25.37M | 21.59M | 12.51M | 155.00K | 180.00K | 31.00K | 0.00 |
| Gross Profit | 3.68M | 12.05M | 32.43M | -3.60M | 10.66M | 10.64M | 9.48M | 6.16M | 3.33M | -23.94M | -20.49M | -12.14M | 563.00K | 31.00K | -11.00K | 0.00 |
| Gross Profit Ratio | 12.23% | 21.54% | 43.98% | -42.91% | 21.97% | 21.25% | 19.42% | 32.44% | 14.70% | -1,680.21% | -1,862.73% | -3,290.79% | 78.41% | 14.69% | -55.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 681.00K | 92.00K | 889.00K | 1.51M | 1.74M | 2.02M | 2.36M | 1.98M | 3.11M |
| General & Administrative | 12.96M | 31.17M | 24.20M | 15.94M | 14.32M | 16.24M | 16.58M | 12.86M | 9.62M | 16.37M | 40.37M | 10.23M | 2.78M | 2.07M | 1.57M | 1.41M |
| Selling & Marketing | 7.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 163.00K | -889.00K | 0.00 | 659.00K | 2.19M | 2.10M | 1.75M | 2.77M |
| SG&A | 20.91M | 31.17M | 24.20M | 15.94M | 14.32M | 16.24M | 16.58M | 14.11M | 10.38M | 15.48M | 40.37M | 10.89M | 4.97M | 4.17M | 3.32M | 4.18M |
| Other Expenses | 10.98M | 5.43M | 3.20M | 5.21M | 6.12M | 498.00K | -197.00K | 681.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 31.89M | 36.60M | 27.40M | 21.15M | 20.44M | 25.74M | 24.55M | 28.57M | 13.68M | 21.50M | 41.88M | 12.63M | 6.99M | 6.53M | 5.30M | 7.29M |
| Cost & Expenses | 58.32M | 80.49M | 68.70M | 33.13M | 58.30M | 65.19M | 63.90M | 41.39M | 33.03M | 46.86M | 41.88M | 25.14M | 7.14M | 6.71M | 5.33M | 7.29M |
| Interest Income | 448.00K | 384.00K | 43.00K | 1.83M | 2.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 321.00K | 16.13M | 0.00 | 1.83M | 2.90M | 1.83M | 731.00K | 1.70M | 2.59M | 0.00 | 0.00 | 0.00 | 1.53M | 4.30M | 617.00K | 157.00K |
| Depreciation & Amortization | 3.55M | 7.27M | 4.92M | 7.23M | 6.12M | 9.50M | 6.85M | 1.32M | 3.52M | 4.02M | 5.22M | 2.50M | 61.00K | 87.00K | 113.00K | 107.00K |
| EBITDA | -15.75M | -19.12M | 7.87M | -19.54M | -11.24M | -24.58M | -8.43M | -16.26M | -6.01M | -40.32M | -35.56M | -19.87M | -5.80M | -6.41M | -5.35M | -7.18M |
| EBITDA Ratio | -52.31% | -16.77% | 14.63% | -198.75% | -11.46% | -10.18% | -14.94% | -45.51% | -30.10% | 1,646.81% | -3,144.18% | -6,034.42% | -886.21% | -3,036.97% | -25,965.00% | 0.00% |
| Operating Income | -19.30M | -24.55M | 5.87M | -40.10M | -9.78M | -34.73M | -15.07M | -22.42M | -10.34M | -111.20M | -40.78M | -24.77M | -6.42M | -6.50M | -5.31M | -7.29M |
| Operating Income Ratio | -64.08% | -43.89% | 7.95% | -478.28% | -20.16% | -69.32% | -30.87% | -118.15% | -45.59% | -7,803.23% | -3,707.00% | -6,712.20% | -894.71% | -3,078.20% | -26,530.00% | 0.00% |
| Total Other Income/Expenses | -8.70M | -1.41M | -1.16M | -52.12M | -4.80M | -1.18M | -1.29M | -1.57M | -1.78M | 1.97M | -971.00K | 1.59M | -965.00K | -3.41M | -770.00K | -51.00K |
| Income Before Tax | -27.99M | -32.57M | 3.03M | -92.23M | -20.68M | -35.91M | -16.00M | -24.00M | -12.12M | -109.22M | -41.75M | -20.79M | -7.39M | -9.91M | -6.08M | -7.34M |
| Income Before Tax Ratio | -92.98% | -58.23% | 4.11% | -1,099.88% | -42.62% | -71.68% | -32.77% | -126.50% | -53.44% | -7,664.70% | -3,795.27% | -5,633.06% | -1,029.11% | -4,695.26% | -30,380.00% | 0.00% |
| Income Tax Expense | 35.00K | 55.00K | 140.00K | 7.00K | -146.00K | -278.00K | 111.00K | 13.64M | -866.00K | 65.34M | 11.66M | 55.00K | 90.00K | 35.00K | 73.00K | -7.00K |
| Net Income | -27.74M | -32.63M | 3.35M | -92.23M | -20.53M | -37.21M | -28.84M | -24.01M | -11.16M | -109.68M | -52.43M | -20.84M | -7.48M | -9.94M | -6.15M | -7.33M |
| Net Income Ratio | -92.14% | -58.33% | 4.54% | -1,099.96% | -42.32% | -74.27% | -59.07% | -126.52% | -49.18% | -7,696.63% | -4,766.64% | -5,647.97% | -1,041.64% | -4,711.85% | -30,745.00% | 0.00% |
| EPS | -6.64 | -6.97 | 0.60 | -41.39 | -251.22 | -1.54K | -1.55K | -1.90K | -1.31K | -14.68K | -7.56K | -6.39K | -9.02K | -22.09K | -2.57 | -7.02K |
| EPS Diluted | -6.64 | -6.97 | 0.60 | -41.39 | -251.22 | -1.54K | -1.55K | -1.90K | -1.31K | -14.55K | -7.56K | -6.00K | -9.02K | -22.09K | -2.57 | -7.02K |
| Weighted Avg Shares Out | 4.18M | 4.68M | 5.22M | 2.23M | 81.72K | 24.23K | 18.57K | 12.64K | 8.51K | 7.47K | 6.93K | 3.26K | 829.00 | 450.00 | 2.39M | 1.05K |
| Weighted Avg Shares Out (Dil) | 4.18M | 4.68M | 5.25M | 2.23M | 81.72K | 24.23K | 18.57K | 12.64K | 8.51K | 7.54K | 6.94K | 3.47K | 829.00 | 450.00 | 2.39M | 1.05K |
XWELL, Inc. Announces 1-for-20 Reverse Stock Split
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), announced today that it will effect a 1-for-20 reverse stock split of its common stock effective at 5:00 pm Eastern Time on Wednesday, September 27, 2023. Shares of...
XWELL Introduces New Stretch Service at XpresSpa
NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, continues to evolve its service offerings with the introduction of a proprietary stretching service...
XWELL Grows Footprint Outside the Airport with Acquisition of Naples Wax Center
Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for...
XWELL, Inc. (XWEL) Q2 2023 Earnings Call Transcript
XWELL, Inc. (NASDAQ:XWEL ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Suzanne Scrabis - CFO Scott Milford - CEO Operator Greetings. Welcome to XWELL's Second Quarter 2023 Earnings Conference Call.
XWELL Extends Collaboration with Centers for Disease Control and Prevention's Traveler-Based Genomic Surveillance Program
Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports Since August 2021, the program has served as a critical monitoring system for biological threats,...
XWELL, Inc. Reports Second Quarter 2023 Results
NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today reported results for the second quarter ended June 30, 2023.
XWELL, Inc. to Announce Second Quarter 2023 Financial Results on Monday, August 14
NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release second quarter 2023 financial results on...
XpresSpa Debuts Clockwork Robotic Manicures at Miami International Airport
NEW YORK, July 20, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, in partnership with Clockwork, the pioneer in robotics for the beauty industry,...
XWELL Unveils “XWELL Rewards” Loyalty Program
Refreshed program furthers XWELL's transformation to meet the needs of today's travelers Refreshed program furthers XWELL's transformation to meet the needs of today's travelers
XWELL, Inc. Appoints Suzanne Scrabis as Chief Financial Officer
NEW YORK, July 13, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), an authority in health and wellness solutions for people on the go, today announced the appointment of Suzanne A. Scrabis as Chief Financial Officer of the Company, effective...
Source: https://incomestatements.info
Category: Stock Reports